Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Chinary is a specialty pharmaceutical company headquartered in Shenzhen, China, dedicated to the research, development, and manufacturing of advanced drug delivery systems. The company focuses on high-barrier formulations, including transdermal patches, topical gels, and complex injectables, primarily targeting the central nervous system, pain management, and respiratory therapeutic areas. Their product portfolio features several transdermal patches for conditions such as Alzheimer's disease, Parkinson's disease, and asthma, designed to provide controlled release and improved patient adherence. Shenzhen Chinary maintains state-of-the-art R&D centers and GMP-compliant manufacturing facilities to support its pipeline of generic and innovative drug products. The company aims to expand its footprint in the global specialty pharma market through technological innovation and strategic partnerships.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhen Chinary.